๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Long-term ursodeoxycholic acid therapy delays histologic progression in primary biliary cirrhosis

โœ Scribed by Angulo, P.; Batts, K.P.; Therneau, T.M.; Jorgensen, R.A.; Dickson, E.R.; Lindor, K.D.

Book ID
122966383
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
150 KB
Volume
114
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Long-term ursodeoxycholic acid delays hi
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
โœ Paul Angulo; Kenneth P. Batts; Terry M. Therneau; Roberta A. Jorgensen; E. Rolla ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 50 KB ๐Ÿ‘ 1 views

Primary biliary cirrhosis (PBC) is a progressive cholestatic liver disease frequently leading to development of cirrhosis and its complications. Ursodeoxycholic acid (UDCA) is a beneficial medical therapy for patients with PBC. Improvement in some histological features, but not in histological stage

Ursodeoxycholic acid therapy in primary
Ursodeoxycholic acid therapy in primary biliary cirrhosis
โœ David E. J. Jones; Oliver F. W. James; Margaret F. Bassendine ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 703 KB

BackgroundlAims: A double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) was conducted in 180 patients with primary biliary cirrhosis (PBC) to define the efficacy and safety of UDCA Efficacy was assessed by time to treatment failure defined as death; liver transplantation; histologic